Recent Posts
- PADAGIS ANNOUNCES THE FIRST LAUNCH OF AN OVER-THE-COUNTER NALOXONE NASAL SPRAY IN THE UNITED STATES
- Padagis announces the acquisition of 17,000 square meter facility in Yerucham, Israel
- PADAGIS ANNOUNCES TWO FIRST-TO-FILE ANDA SUBMISSIONS
- PADAGIS ANNOUNCES TWO PRODUCT LAUNCHES
- Padagis Announces FDA Approval and Launch of A-Rated Generic Version of Uceris® (Budesonide 2mg Rectal Foam)
Recent Comments